Conference abstract · 26 May 2023
Conference abstractPublished 27 Jul 2020
Medication Safety during COVID 19
King Abdullah Medical City, Saudi Arabia
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The COVID-19 pandemic and the response of the healthcare system has affected the ability of healthcare to ensure medication safety in several ways. These include challenges associated with medication shortages, changes to the pharmacy workflow, an ever-changing evidence base associated with the pharmaceutical treatment of COVID-19 complications, and limited availability of personal protective equipment (PPE). Pharmacists are the best-positioned professionals to ensure safety through the preparation, delivery, and ongoing management of medications. However, like the majority of healthcare providers, the usual pharmacy workflow and operations have been greatly impacted by the response to COVID-19 have modified the physical settings of care for pharmacists, necessitating changes to their workflows. Additionally, pharmacist workflows may be interrupted or require modification due to increased informatics and technology changes associated with monitoring medication supplies or when systems are operating with a decreased workforce (colleagues are forced to work from home, are sick, or may be furloughed). Lastly, redeployment of healthcare personnel to new areas and specialty of care may introduce safety risks due to unfamiliarity with workflows and processes. For example, the Institute for Safe Medication Practices recently shared a case study in which there was a failure to engage barcode medication administration, a best practice in medication safety, when healthcare staff was assigned to a new patient care area. Also the recommendation of using automation during COVID-19.
Subjects
Infectious DiseasesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Commentary · 4 Jul 2024
A Commentary on: Immunogenicity and Safety of a Recombinant COVID-19 Vaccine as Heterologous Booster After Priming with Inactivated Vaccine in Healthy Children and Adolescents Aged 3-17 Years: An Open-labeled, Single-arm Clinical Trial
Article · 29 Jan 2024
Ensuring Safety: BNT162b2 mRNA COVID-19 Vaccine Batches
Perspective · 29 Apr 2023
Evaluating Immunogenicity and Safety of a Groundbreaking COVID-19 Vaccine: Findings from a Phase III Clinical Trial
Research article · 17 Nov 2021
A Proposed Protocol for the Investigation of the Safety and Efficacy of the COVID-19 Vaccine for Patients with Psychosis and Pilot Safety Findings from a Chinese Psychiatrist’s Self-Experiment
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectInfectious Diseases
- BylineArticles whose byline prints “Fatima Yousef Ghethan”
